deltatrials
Completed OBSERVATIONAL NCT06790407

Observational Metabolic Health Study

A Direct-to-Consumer, Randomized, Double-blind, Placebo-controlled Study With Open-label Extension Investigating the Effects of Mimio Biomimetic Cell Care on Metabolic Health in Healthy Overweight Individuals in a Home Setting

Sponsor: Mimio Health, Inc.

Conditions Healthy
Interventions Mimio Study Product Placebo
Updated 2 times since 2025 Last updated: May 6, 2025 Started: Aug 26, 2024 Primary completion: Dec 27, 2024 Completion: Jan 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Healthy and is currently completed. Mimio Health, Inc. leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Feb 2025 – ~Jun 2025 · 4 months · monthly snapshotRecruiting~Jun 2025 – present · 13 months · monthly snapshotCompleted

Change History

2 versions recorded

  1. Jun 2025 — Present [monthly]

    Completed

    Status: Recruiting → Completed

  2. Feb 2025 — Jun 2025 [monthly]

    Recruiting

    First recorded

Aug 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mimio Health, Inc.
  • People Science, Inc.
Data source: Mimio Health, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations